Abstract:Globally, SARS-CoV-2 has negatively impacted many lives and industries due to its rapid spread, severe outcomes, and the need for the implementation of lockdown strategies across the world. SARS-CoV-2 disease severity varies among different populations. Host genetics have been associated with various diseases, and their ability to alter disease susceptibility and severity. In addition, Human Leukocyte Antigen (HLA) expression levels and alleles vary significantly among ethnic groups, which might impact the host's response to SARS-CoV-2. Our previous study highlighted that HLA-A might have an effect on COVID-19 disease severity across ethnicities. Therefore, in this study, we aim to examine the effect of HLA-B and C expression levels on COVID-19 disease severity. To achieve this, we used real-time PCR to measure the HLA mRNA expression levels of SARS-CoV-2-infected individuals from a South African cohort and compared them across ethnic groups, disease outcomes, gender, comorbidities, and age. Our results show (1) that the effect of HLA-B mRNA expression levels was associated with differences in disease severity when we compare symptomatic vs. asymptomatic (p < 0.0001). While HLA-C mRNA expression levels were not associated with COVID-19 disease severity. (2) In addition, we observed that HLA-B and HLA-C mRNA expression levels were significantly different between South African Black individuals and South African Indian individuals (p < 0.0001, p < 0.0001). HLA-B mRNA expression levels among symptomatic South African Black individuals were significantly higher than symptomatic South African Indian individuals (p 0.0001). HLA-C mRNA expression levels among symptomatic South African Black individuals were significantly higher than among symptomatic South African Indian individuals (p = 0.0217). (3) HLA-C expression levels were significantly different between males and females (p = 0.0052). In addition, asymptomatic males are higher than asymptomatic females (p = 0.0375). (4) HLA-B expression levels were significantly different between individuals with and without comorbidities (p = 0.0009). In addition, we observed a significant difference between individuals with no comorbidities and non-communicable diseases (p = 0.0034), in particular, hypertension (p = 0.0487). (5) HLA-B expression levels were significantly different between individuals between 26–35 and 56–65 years (p = 0.0380). Our work is expected to strengthen the understanding of the relationship between HLA and COVID-19 by providing insights into HLA-B and C expression levels across ethnic populations in South Africa among COVID-19-symptomatic and asymptomatic individuals. Our results highlight that HLA-B mRNA expression levels contribute to COVID-19 severity as well as variation in ethnicities associated with COVID-19. Further studies are needed to examine the effect of HLA expression levels across various ethnic groups with contributing factors.

Distribution of HLA allele frequencies in 82 Chinese individuals with coronavirus disease‐2019 (COVID‐19)

[An Investigation of the Polymorphism of HLA Class II Alleles in the Han Population in Hubei Province of China].

The Polymorphisms of HLA Class Ⅰ and Ⅱalleles Were Not Associated with Severe Acute Respiratory Syndrome among Recovered Patients in Beijing: a Case-Control Study

Association of HLA Classⅰand Classⅱgenes with Severe Acute Respiratory Syndrome in the Northern Chinese Population

Analysis of KIR and HLA Polymorphism in Chinese Individuals With COVID‐19

HLA predictions from the bronchoalveolar lavage fluid samples of five patients at the early stage of the Wuhan seafood market COVID-19 outbreak

The role of HLA genetic variants in COVID‐19 susceptibility, severity, and mortality: A global review

Allele and Haplotype Frequencies of Human Leukocyte Antigen-A, -B, -C,-DRB1, and -DQB1 in Chinese Patients with Hematological Diseases

The Distributions Of Hla-A, Hla-B, Hla-C, Hla-Drb1 And Hla-Dqb1 Allele And Haplotype At High-Resolution Level In Zhejiang Han Population Of China

The Pathogen Adaptation of HLA Alleles and the Correlation with Autoimmune Diseases based on the HLA Diversity Resource in the Han Chinese

HLA-B and C Expression Contributes to COVID-19 Disease Severity within a South African Cohort

Investigation of HLA susceptibility alleles and genotypes with hematological disease among Chinese Han population

Relationships Between Polymorphisms in HLA-G 3'UTR Region and COVID-19 Disease Severity

The polymorphism of HLA‐A, ‐C, ‐B, ‐DRB3/4/5, ‐DRB1, ‐DQB1 loci in Zhejiang Han population, China using NGS technology

Association of Human Leukocyte Antigen Alleles with COVID-19 Severity and Mortality in a Spanish Population

Predictors of COVID-19 Infection: A Prevalence Study of Hospitalized Patients

Association Between ABO Blood Group System and COVID-19 Susceptibility in Wuhan

Genome-wide association study of COVID-19 severity among the Chinese population

HLA-C Peptide Repertoires as Predictors of Clinical Response during Early SARS-CoV-2 Infection

Association between human leukocyte antigen alleles and COVID-19 disease severity

Individuals carrying the HLA-B*15 allele exhibit favorable responses to COVID-19 vaccines but are more susceptible to Omicron BA.5.2 and XBB.1.16 infection